Get the Stockscreener App
13.39
0.22%
-0.035
Organon Co stock is traded at $13.39, with a volume of 889.43K.
It is down -0.22% in the last 24 hours and down -0.22% over the past month.
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
See More
Previous Close:
$13.43
Open:
$13.42
24h Volume:
889.43K
Relative Volume:
0.11
Market Cap:
$3.52B
Revenue:
$6.16B
Net Income/Loss:
$246.00M
P/E Ratio:
14.27
EPS:
0.9387
Net Cash Flow:
$708.00M
1W Performance:
-0.30%
1M Performance:
-0.22%
6M Performance:
+91.98%
1Y Performance:
+37.44%
1-Day Range:
$13.39
$13.44
1-Week Range:
$13.39
$13.47
52-Week Range:
$5.69
$13.49
Organon Co Stock (OGN) Company Profile
Name
Organon Co
Sector
Industry
Phone
551-430-6000
Address
30 HUDSON STREET, JERSEY CITY
Compare OGN vs LLY, JNJ, ABBV, MRK, NVS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
13.39 | 3.53B | 6.16B | 246.00M | 708.00M | 0.9387 |
LLY
Lilly Eli Co
|
1,112.78 | 979.64B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
231.02 | 549.78B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
232.07 | 382.49B | 62.82B | 3.60B | 19.98B | 2.0274 |
MRK
Merck Co Inc
|
115.15 | 281.24B | 65.51B | 8.93B | 14.12B | 3.5532 |
NVS
Novartis Ag Adr
|
149.16 | 280.64B | 54.66B | 13.58B | 16.05B | 7.0171 |
Organon Co Stock (OGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Underweight |
| Oct-27-25 | Downgrade | Piper Sandler | Overweight → Underweight |
| May-02-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Sep-06-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-03-23 | Downgrade | Goldman | Buy → Neutral |
| Sep-21-23 | Initiated | Barclays | Overweight |
| Mar-16-23 | Initiated | Raymond James | Outperform |
| Oct-14-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-06-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-27-22 | Initiated | Goldman | Buy |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-07-21 | Initiated | Piper Sandler | Neutral |
| Sep-01-21 | Initiated | BofA Securities | Buy |
| Jul-22-21 | Initiated | Citigroup | Buy |
| Jun-15-21 | Initiated | JP Morgan | Neutral |
| Jun-11-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-10-21 | Initiated | Evercore ISI | Outperform |
View All
Organon Co Stock (OGN) Latest News
Organon secures global licensing deal for MIUDELLA copper IUD - grafa.com
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Organon completes licensing deal for hormone-free IUD Miudella - Investing.com
Organon completes licensing deal for hormone-free IUD Miudella By Investing.com - Investing.com Canada
Organon wins rights to first U.S. hormone-free copper IUD in 40 years - Stock Titan
OGN Stock Set For Blastoff? Sun Pharma Offers 24% Premium In All-Cash Buyout Deal - Stocktwits
Lombard Odier Asset Management (USA) Corp's Organon & Co(OGN) Holding History - GuruFocus
Samsung Bioepis, Organon expand Stelara biosimilar partnership to Canada - koreabiomed.com
OGNOrganon & Co Stock Price and Quote - Finviz
Organon and Samsung Bioepis Expand Agreement to Commercialize PYZCHIVA - Business Wire
Organon and Samsung Bioepis expand Canadian biosimilar deal - grafa.com
Samsung Bioepis and Organon Expand Agreement to Commercialize PYZCHIVA®, a Biosimilar Referencing STELARA® in Canada - Businesskorea
Organon gains rights to Samsung biosimilar in Canada By Investing.com - Investing.com Nigeria
Organon gains rights to Samsung biosimilar in Canada - Investing.com
Organon wins FDA nod to expand TOFIDENCE use in severe CRS & COVID-19 - MSN
Organon & Co (OGN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
FDA expands Organon’s tocilizumab biosimilar indications By Investing.com - Investing.com Nigeria
Organon & Co (OGN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Organon & Co (OGN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Organon & Co (OGN) Institutional Confidence - TradingKey
Organon & Co (OGN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Organon & Co (OGN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Organon & Co (OGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Organon & Co. (OGN) Shareholder/Analyst CallSlideshow (NYSE:OGN) 2026-06-17 - Seeking Alpha
Sun Pharma to buy Organon for $11.75B in record overseas deal - MSN
Organon (OGN) agrees to $14.00 cash merger; special meeting July 23, 2026 - Stock Titan
Halper Sadeh LLC is Investigating Whether LPRO, NUVL, OGN, SUNE are Obtaining Fair Deals for their Shareholders - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG), Organon & Co. (NYSE – OGN) - mykxlg.com
Sun Pharma agrees $11.75bn acquisition of Organon - Financier Worldwide
Lost Money on Organon & Co.(OGN)? Join Class Action Suit Seeking RecoveryContact The Gross Law Firm - GuruFocus
Is TOFIDENCE’s Expanded CRS and COVID Label Altering The Investment Case For Organon (OGN)? - Yahoo Finance
Organon (OGN) director Shalini Sharp receives 17,857 phantom stock units as cash-settled award - Stock Titan
Organon (OGN) director Ramona Sequeira receives 17,857 phantom stock units as cash-settled award - Stock Titan
Organon (OGN) director receives 17.8K phantom stock units as compensation - Stock Titan
Organon (OGN) director granted cash-settled phantom stock tied to shares - Stock Titan
Organon (OGN) director awarded 17,857 phantom stock units as cash-settled compensation - Stock Titan
Organon (OGN) director receives phantom stock award, lifting holdings above 81,000 units - Stock Titan
Organon & Co | 4: Statement of changes in beneficial ownership of securities-Director Gayle Helene D - Moomoo
Organon (OGN) director awarded 17,857 phantom stock units under savings plan - Stock Titan
Organon (OGN) director Alan Ezekowitz awarded 17,857 phantom stock units - Stock Titan
Organon (OGN) director awarded phantom stock units tied to shares - Stock Titan
Organon (OGN) Stock After New TOFIDENCE Approval A Fresh Look At Valuation And Recovery Potential - Yahoo Finance
Sun Pharma to acquire US-based Organon in nearly $11.75 billion deal - DD News
Press Release: Organon Reports Results for the First Quarter Ended March 31, 2026 - Moomoo
Organon Shareholders Approve Board, Pay and Incentive Plan - The Globe and Mail
Organon & Co. Announces Results of 2026 Annual Meeting and Approves Incentive Stock Plan in Form 8-K Filing - Minichart
Organon Wins FDA Nod to Expand TOFIDENCE Use in Severe CRS & COVID-19 - Zacks Investment Research
Sector Gamma AS Has $2.15 Million Stock Position in Organon & Co. $OGN - MarketBeat
Private Management Group Inc. Acquires 1,204,979 Shares of Organon & Co. $OGN - MarketBeat
Organon & Co stock hits 52-week high at 13.48 USD - Investing.com Nigeria
Organon (NYSE: OGN) holders back amended 2021 incentive plan adding 8M shares - Stock Titan
Organon Co Stock (OGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.36%
0.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):